Guangdong Raynovent Biotech Co., Ltd
Clinical trials sponsored by Guangdong Raynovent Biotech Co., Ltd, explained in plain language.
-
New flu drug shows promise in kids – phase 2 trial complete
Symptom relief CompletedThis study tested a new flu medicine called ZSP1273 in 72 children aged 2 to 17 who had influenza A. The goal was to check how safe the drug is, how it moves through the body, and how well it works. Researchers measured drug levels in the blood, tracked side effects, and recorded…
Phase: PHASE2 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated May 26, 2026 07:56 UTC
-
New obesity drug RAY1225 enters human safety testing
Symptom relief CompletedThis early-stage study tested a new drug called RAY1225 in 68 healthy and obese adults to see if it is safe and how the body processes it. Researchers measured side effects, weight changes, and waist size. The goal is to gather initial safety data before larger trials can explore…
Phase: PHASE1 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated May 26, 2026 07:27 UTC